当前位置: X-MOL 学术J Chromatogr Sci › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Development and Validation of UPLC Tandem Mass Spectrometry Assay for Ceftibuten and Sulbactam in Human Plasma
Journal of Chromatographic Science ( IF 1.3 ) Pub Date : 2024-03-24 , DOI: 10.1093/chromsci/bmae010
Karla Paulina Valero-Rivera 1, 2 , Martin Magaña-Aquino 3 , María del Carmen Romero-Méndez 1, 2 , Miriam Nayeli Morales-Barragán 1, 2 , Julia Sagahón-Azúa 1, 2 , Susanna Edith Medellín-Garibay 1, 2 , Rosa del Carmen Milán-Segovia 1, 2 , Fidel Martínez-Gutiérrez 1, 2 , Silvia Romano-Moreno 1, 2
Affiliation  

A sensitive and rapid ultra-performance liquid chromatography coupled with -tandem mass spectrometry (UPLC-MS/MS) method was developed and validated to determine ceftibuten (CTB) and sulbactam (SUL) in human plasma. An ACQUITY UPLC HSS T3 C18 (2.1 × 100 mm), 1.8 μm column with gradient elution of water (0.1% formic acid) and acetonitrile was used for separation at a flow rate of 0.2 mL/min. This method involves a simple sample preparation with acetonitrile. The calibration curves of CTB and SUL in plasma showed good linearity over the concentration range of 0.50–25 μg/mL and with a correlation coefficient (r2) >0.99. This method was validated in terms of selectivity, linearity, precision, accuracy and stability. High precision was obtained with coefficients of variation <15%. Excellent recovery in the range of 90–104% was achieved for CTB and SUL was 86–110%. The method has the potential utility to support pharmacometric modeling in clinical practice and biopharmaceutic studies.

中文翻译:

人血浆中头孢布烯和舒巴坦的 UPLC 串联质谱分析的开发和验证

开发并验证了一种灵敏快速的超高效液相色谱结合串联质谱 (UPLC-MS/MS) 方法来测定人血浆中的头孢布烯 (CTB) 和舒巴坦 (SUL)。采用 ACQUITY UPLC HSS T3 C18 (2.1 × 100 mm)、1.8 μm 色谱柱,用水(0.1% 甲酸)和乙腈梯度洗脱,以 0.2 mL/min 的流速进行分离。该方法涉及用乙腈进行简单的样品制备。血浆中CTB和SUL的校准曲线在0.50-25μg/mL的浓度范围内表现出良好的线性,相关系数(r2)>0.99。该方法在选择性、线性、精密度、准确度和稳定性方面得到了验证。获得了高精度,变异系数<15%。 CTB 的回收率达到了 90-104%,SUL 的回收率为 86-110%。该方法具有支持临床实践和生物制药研究中药效学建模的潜在用途。
更新日期:2024-03-24
down
wechat
bug